Taylor Schreiber
Förmögenhet: 16 M $ per 2026-05-31
Förmögenhet: 16 M $ per 2026-05-31
Taylor H.
Schreiber is the founder of Shattuck Labs, Inc., established in 2016, serving as Chief Executive Officer & Director since 2020.
Former jobs include Director at Pelican Therapeutics, Inc. from 2011 to 2017 and Chief Scientific Officer at Scorpius Holdings, Inc. from 2015 to 2016.
Education includes undergraduate studies at Bucknell University and a doctorate from The University of Miami Leonard M.
Miller School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SHATTUCK LABS, INC. 3,56 % | 2026-05-12 | 2 732 972 ( 3,56 % ) | 16 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| SHATTUCK LABS, INC. | Grundare | 2016-01-01 |
| Företag | Position | Slut |
|---|---|---|
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic biological agents for immuno-oncology combinations | Direktör/Styrelseledamot | 2017-01-01 |
| SCORPIUS HOLDINGS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2016-12-31 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Scorpius Holdings, Inc.
Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic biological agents for immuno-oncology combinations | Health Technology |
Bucknell University
Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Miami Leonard M. Miller School of Medicine
The University of Miami Leonard M. Miller School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shattuck Labs, Inc.
Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån